middle.news
ReNerve Expands Trial After Nerve Cuff Cuts Post-Surgery Pain Dramatically
1:07am on Sunday 21st of December, 2025 AEDT
•
Healthcare
Read Story
ReNerve Expands Trial After Nerve Cuff Cuts Post-Surgery Pain Dramatically
1:07am on Sunday 21st of December, 2025 AEDT
Key Points
Clinical trial cohort expanded to 240 patients across multiple US centers
Interim data shows post-surgery pain scores drop from 7.1 to 0.4 with NervAlign®
Study compares standard nerve repair care with and without the NervAlign® Nerve Cuff
Recruitment expected to complete by mid-2026, supporting European market approval
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Renerve (ASX:RNV)
OPEN ARTICLE